Novartis Invests $745M to Compete with BMS and Lilly in the …

Novartis Invests $745M To Compete With BMS And Lilly In The …

6 days from now

4 days ago  · This collaboration strengthens Novartis’ position in the competitive radiopharmaceutical market, where it faces rivals like Bristol Myers Squibb (BMS) and Eli Lilly. …

geneonline.com

Novartis Taps Ratio For $745M Radiopharmaceutical Pact

6 days from now

Nov 15, 2024  · Novartis is adding another radiopharmaceutical program to its collection, penning a deal worth $745 million in biobucks for rights to a cancer candidate from Ratio Therapeutics.

fiercebiotech.com

Novartis Strikes Radiopharma Deal With Ratio Worth Up To $745M

6 days from now

4 days ago  · Novartis and Ratio Therapeutics announced a collaboration deal worth up to $745 million, focusing on SSTR2 radiotherapeutic cancer treatment. Ratio will receive an …

endpts.com

BioSpace: Biotech, Pharmaceutical And Clinical Research News

6 days from now

Novartis Drops Up to $745M to Move Deeper Into Competitive Radiopharma Space The deal has secured Novartis the chance to work with Ratio Therapeutics on a novel drug candidate that …

biospace.com

Drug Development News - BioSpace

6 days from now

Novartis Drops Up to $745M to Move Deeper Into Competitive Radiopharma Space. The deal has secured Novartis the chance to work with Ratio Therapeutics on a novel drug candidate that …

biospace.com

Radio Pharma Archives - PharmaLive

6 days from now

Novartis drops up to $745M to move deeper into competitive radiopharma space Therapeutics The deal has secured Novartis the chance to work with Ratio Therapeutics on a novel drug …

pharmalive.com

Fengqian Chen, Ph.D. On LinkedIn: Novartis Drops Up To $745M To …

6 days from now

Novartis Steps Up in the #Radiopharma Race with a $745M Deal! 🚀 Novartis is doubling down on its radiopharmaceutical ambitions, striking a deal worth up to $745M with Ratio Therapeutics …

linkedin.com

Novartis, Ono Latest To Announce Billion-Dollar M&A Deals

6 days from now

Mar 5, 2024  · May 2. Status: Pending. Deal value: Up to $1.75 billion. Novartis announced plans to acquire radiopharmaceutical company Mariana Oncology for $1 billion upfront, with …

biospace.com

Novartis Retreats From TIGIT, Handing $300M Drug Back To BeiGene

6 days from now

Jul 11, 2023  · Under the agreement, if Novartis had taken up its option to acquire the rights to the drug in the U.S., Europe, Japan and other territories by late 2023 then it would have to hand …

fiercebiotech.com